–Intent-to-Treat Analysis Shows Statistically Significant Reduction in Tumour Burden as Measured by CA-125–
CALGARY, March 21, 2016 /CNW/ – Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (FRA: ONY) (“Oncolytics” or the “Company”) today announced an update for a…